Lara Meisner, General Counsel and Secretary at Viridian Therapeutics, Inc.\DE (VRDN), sold 1,597 shares at $28.08 ($45K) on 2022-12-15, disclosed to the SEC on 2022-12-19.
Scheduled sale ($45k) by General Counsel and Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.08 | 300 | $8K | 18.6% |
| 2 | $28.44 | 1,297 | $37K | 81.4% |
| Total | $28.37 avg | 1,597 | $45K | 100% |
| Filing → |
| BCAX | SELL | 2025-06-18 | $330K | — | Filing → |
| BCAX | SELL | 2025-03-18 | $2.0M | — | Filing → |
| VRDN | SELL | 2023-06-20 | $128K | — | Filing → |